CD44 and breast carcinoma: The growth-inhibitory and tumor-suppressive effects of p53 act in part via its ability to bind to a non-canonical sequence in the CD44 promoter, thus inhibiting CD44 expression and downstream tumor-promoting signaling in breast cancer cells (207).